Rowan Legal has advised CasInvent Pharma on the successful closing of a new investment round. Kristyna & Mikulas advised i&i Prague and Havel & Partners advised the Holecek Family Foundation as the investors. Hladky Legal reportedly advised other investors.
CasInvent Pharma is a Czech biotechnology company. According to Rowan Legal, the round is aimed at launching the clinical development of its innovative CK1 inhibitors, a novel approach in the treatment of resistant cancers.
The Rowan Legal team included Partners Jan Frey and Jan Tomisek and Attorneys at Law Tereza Jiraskova and Kristyna Kupcova.
The Kristyna & Mikulas team included Partner Mikulas Vargic and Attorney at Law Diana Urbaskova.
The Havel & Partners team included Partner Martin Peckl and Associate Tomas Jansa.